EW

Edwards Lifesciences Corporation

Healthcare Medical Devices NYSE

About the company

Founded in 2000 as a spin-off from Baxter International, Edwards Lifesciences has quickly risen to become a leader in the medical device industry. With its focus on advanced stages of structural heart disease, the company designs, manufactures, and markets a wide range of innovative products that improve patients' quality of life. One of the company's flagship products is surgical tissue heart valves. These valves are meticulously crafted to replace damaged or diseased heart valves, offering patients a new lease on life. Edwards Lifesciences combines cutting-edge technology with exceptional craftsmanship to develop surgical tissue heart valves that are both effective and durable. In recent years, transcatheter valve technologies have emerged as a breakthrough in the treatment of heart disease. Edwards Lifesciences has been at the forefront of this groundbreaking field, developing transcatheter valve products that can be implanted without the need for open-heart surgery. These minimally invasive procedures offer patients a faster recovery time and reduced risks compared to traditional surgical approaches. Beyond heart valves, Edwards Lifesciences also designs and manufactures other essential medical devices. Surgical clips play a critical role in various surgical procedures, and the company has developed innovative clips that ensure secure closure and minimize post-surgical complications. Catheters are another area of expertise for the company, providing physicians with the tools they need to perform precise procedures and interventions. Additionally, Edwards Lifesciences offers monitoring systems that measure a patient's heart function during surgery. These systems provide surgeons with crucial real-time information, allowing them to make informed decisions and ensure the best possible outcome for their patients. By continuously monitoring the patient's heart function, the risk of complications can be minimized, and surgical procedures can be performed more safely and efficiently. With a global presence, Edwards Lifesciences derives a significant portion of its total sales from international markets. This global reach allows the company to impact the lives of patients around the world. By partnering with healthcare professionals from different countries and cultural backgrounds, Edwards Lifesciences can tailor its solutions to meet the unique needs of diverse patient populations. The success of Edwards Lifesciences can be attributed to its commitment to research and development. The company invests heavily in scientific breakthroughs, constantly working towards the development of new and improved medical devices. By collaborating with leading medical institutions, Edwards Lifesciences stays at the forefront of technological advancements in the field of structural heart disease treatment. In summary, Edwards Lifesciences is a cutting-edge medical device company that focuses on providing innovative solutions for advanced stages of structural heart disease. From surgical tissue heart valves to transcatheter valve technologies, their products revolutionize patient care by improving outcomes and offering less invasive treatment options. With its global presence and commitment to research and development, Edwards Lifesciences continues to transform the lives of patients worldwide.

Website: https://www.edwards.com

Data updated: June 2, 2026

Sector comparison

We compare this company with the typical (middle) company in the same industry to show how it looks against similar businesses. This is information, not a recommendation.

Healthcare · 1346 peers in sector

Metric EW Sector median Vs. industry
P/E 47.65 20.10 ↑ Above average
EPS 1.85 USD -1.14 USD ↑ Above average
Dividend yield 0.00% 0.00%
Profit margin 17.39% 0.00% ↑ Above average
ROE 10.46% -58.84% ↑ Above average

Higher and lower here are only a comparison with the typical company in the industry — a higher or lower value on its own does not mean better or worse.

Financial statements & historical data

Income statements, balance sheets, cash flow, earnings and dividend history are available for registered users

Sign up for free

AI Summary

AI-generated company analysis is available for registered users.

Sign up for free

Where does this data come from?

Frequently Asked Questions

What is Edwards Lifesciences Corporation?
Founded in 2000 as a spin-off from Baxter International, Edwards Lifesciences has quickly risen to become a leader in the medical device industry. With its focus on advanced stages of structural heart disease, the company designs, manufactures, and markets a wide range of innovative products that improve patients' quality of life. One of the company's flagship products is surgical tissue heart valves. These valves are meticulously crafted to replace damaged or diseased heart valves, offering patients a new lease on life. Edwards Lifesciences combines cutting-edge technology with exceptional craftsmanship to develop surgical tissue heart valves that are both effective and durable. In recent years, transcatheter valve technologies have emerged as a breakthrough in the treatment of heart disease. Edwards Lifesciences has been at the forefront of this groundbreaking field, developing transcatheter valve products that can be implanted without the need for open-heart surgery. These minimally invasive procedures offer patients a faster recovery time and reduced risks compared to traditional surgical approaches. Beyond heart valves, Edwards Lifesciences also designs and manufactures other essential medical devices. Surgical clips play a critical role in various surgical procedures, and the company has developed innovative clips that ensure secure closure and minimize post-surgical complications. Catheters are another area of expertise for the company, providing physicians with the tools they need to perform precise procedures and interventions. Additionally, Edwards Lifesciences offers monitoring systems that measure a patient's heart function during surgery. These systems provide surgeons with crucial real-time information, allowing them to make informed decisions and ensure the best possible outcome for their patients. By continuously monitoring the patient's heart function, the risk of complications can be minimized, and surgical procedures can be performed more safely and efficiently. With a global presence, Edwards Lifesciences derives a significant portion of its total sales from international markets. This global reach allows the company to impact the lives of patients around the world. By partnering with healthcare professionals from different countries and cultural backgrounds, Edwards Lifesciences can tailor its solutions to meet the unique needs of diverse patient populations. The success of Edwards Lifesciences can be attributed to its commitment to research and development. The company invests heavily in scientific breakthroughs, constantly working towards the development of new and improved medical devices. By collaborating with leading medical institutions, Edwards Lifesciences stays at the forefront of technological advancements in the field of structural heart disease treatment. In summary, Edwards Lifesciences is a cutting-edge medical device company that focuses on providing innovative solutions for advanced stages of structural heart disease. From surgical tissue heart valves to transcatheter valve technologies, their products revolutionize patient care by improving outcomes and offering less invasive treatment options. With its global presence and commitment to research and development, Edwards Lifesciences continues to transform the lives of patients worldwide.
Are Edwards Lifesciences Corporation shares expensive?
The price-to-earnings (P/E) ratio of Edwards Lifesciences Corporation is 47.65 — the share price is 47.65 times the annual profit per share. That is higher than the typical company in the same industry (industry median: 20.10). This is information, not a recommendation. (as of 2026-06-02)
How big is Edwards Lifesciences Corporation?
The market capitalization of Edwards Lifesciences Corporation — the combined value of all its shares — is 50.76 B USD. The higher the market cap, the larger the company. (as of 2026-06-02)
Does Edwards Lifesciences Corporation pay dividends?
The dividend yield of Edwards Lifesciences Corporation is 0.00% — it shows the annual dividend relative to the share price. This is information, not a recommendation. (as of 2026-06-02)
What sector does Edwards Lifesciences Corporation belong to?
Edwards Lifesciences Corporation operates in the Healthcare sector, industry: Medical Devices.

What do you gain?

With Ecrumen you gain full control over your investments and assets!

All your assets
Stock market investments, real estate, bonds. Be aware of what you have in your portfolio!
AI at the service of your investments
Analyze and optimize your investments using the latest technologies. Sentiments, analyses, tips, reports. Always with up-to-date data!
A community eager to help
Find a place with people similar to you. Share your opinions, see how others manage their investments. Get help with the problems that bother you!
What do you gain?

Want to stay up to date?

Subscribe to our newsletter to stay up to date with Ecrumena news and market information. No spam, unsubscribe in one click.

For more information, please refer to our terms of use.

0/120